State Street Corp Axsome Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 916,808 shares of AXSM stock, worth $90.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

916,808

Previous 938,503 2.31%

Holding current value

$90.5 Million

Previous $75.5 Million 9.04%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $1.71 Million - $2.08 Million	-21,695 Reduced 2.31%	916,808 $82.4 Million
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $13,998 - $17,146	-213 Reduced 0.02%	938,503 $75.5 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $1.01 Million - $1.42 Million	14,526 Added 1.57%	938,716 $74.9 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $3.25 Million - $4.73 Million	56,543 Added 6.52%	924,190 $73.6 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $2.94 Million - $3.49 Million	42,458 Added 5.15%	867,647 $60.6 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $1.7 Million - $2.63 Million	29,144 Added 3.66%	825,189 $59.3 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $2.29 Million - $2.94 Million	39,175 Added 5.18%	796,045 $49.1 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $1.82 Million - $3.63 Million	45,538 Added 6.4%	756,870 $58.4 Million
Q3 2022 Nov 15, 2022	SELL	$36.06 - $69.85 $5.11 Million - $9.89 Million	-141,651 Reduced 16.61%	711,332 $31.7 Million
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $3.35 Million - $7.2 Million	153,977 Added 22.03%	852,983 $32.7 Million
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $1.11 Million - $1.94 Million	-46,901 Reduced 6.29%	699,006 $28.9 Million
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $1.22 Million - $1.72 Million	-39,666 Reduced 5.05%	745,907 $28.2 Million
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $2.9 Million - $9.95 Million	145,816 Added 22.79%	785,573 $25.9 Million
Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $536,121 - $778,291	10,589 Added 1.68%	639,757 $43.2 Million
Q1 2021 May 17, 2021	SELL	$55.91 - $81.44 $807,843 - $1.18 Million	-14,449 Reduced 2.24%	629,168 $35.6 Million
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $684,120 - $892,626	-10,317 Reduced 1.58%	643,617 $52.4 Million
Q3 2020 Nov 10, 2020	SELL	$68.34 - $85.84 $4.56 Million - $5.73 Million	-66,792 Reduced 9.27%	653,934 $46.6 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $2.96 Million - $5.86 Million	59,411 Added 8.98%	720,726 $59.3 Million
Q1 2020 May 11, 2020	BUY	$41.2 - $101.31 $27.2 Million - $67 Million	661,315 New	661,315 $38.9 Million

Others Institutions Holding AXSM

# of Institutions

326

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.23B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Axsome Therapeutics, Inc. Transaction History